chr8-19405867-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_001354483.2(CSGALNACT1):​c.1512C>A​(p.His504Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H504R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

CSGALNACT1
NM_001354483.2 missense

Scores

4
7
7

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0430

Publications

0 publications found
Variant links:
Genes affected
CSGALNACT1 (HGNC:24290): (chondroitin sulfate N-acetylgalactosaminyltransferase 1) This gene encodes an enzyme that transfers N-acetylglucosamine (GalNAc) to the core tetrasaccharide linker and to elongating chondroitin sulfate chains in proteoglycans. Knockout of the orthologous mouse gene indicates that the protein is necessary for normal cartilage development and aggrecan metabolism. Mutations in this gene are associated with multiple sclerosis progression, and with mild skeletal dysplasia and joint laxity. [provided by RefSeq, Aug 2017]
CSGALNACT1 Gene-Disease associations (from GenCC):
  • skeletal dysplasia, mild, with joint laxity and advanced bone age
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.811

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001354483.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSGALNACT1
NM_001354483.2
MANE Select
c.1512C>Ap.His504Gln
missense
Exon 9 of 9NP_001341412.1Q8TDX6-1
CSGALNACT1
NM_001130518.2
c.1512C>Ap.His504Gln
missense
Exon 10 of 10NP_001123990.1Q8TDX6-1
CSGALNACT1
NM_001354475.2
c.1512C>Ap.His504Gln
missense
Exon 10 of 10NP_001341404.1Q8TDX6-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSGALNACT1
ENST00000692225.2
MANE Select
c.1512C>Ap.His504Gln
missense
Exon 9 of 9ENSP00000509853.1Q8TDX6-1
CSGALNACT1
ENST00000332246.10
TSL:1
c.1512C>Ap.His504Gln
missense
Exon 10 of 10ENSP00000330805.6Q8TDX6-1
CSGALNACT1
ENST00000454498.6
TSL:1
c.1512C>Ap.His504Gln
missense
Exon 10 of 10ENSP00000411816.2Q8TDX6-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000795
AC:
2
AN:
251430
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461886
Hom.:
0
Cov.:
31
AF XY:
0.00000550
AC XY:
4
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000629
AC:
7
AN:
1112008
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.561
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000171
Hom.:
0
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Uncertain
0.081
D
BayesDel_noAF
Benign
-0.11
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.24
T
Eigen
Benign
0.065
Eigen_PC
Benign
-0.030
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.035
D
MetaRNN
Pathogenic
0.81
D
MetaSVM
Benign
-0.88
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
0.043
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-6.0
D
REVEL
Uncertain
0.40
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.85
MutPred
0.50
Loss of catalytic residue at H504 (P = 0.1006)
MVP
0.26
MPC
0.14
ClinPred
0.99
D
GERP RS
-0.81
Varity_R
0.77
gMVP
0.54
Mutation Taster
=14/86
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs572792017; hg19: chr8-19263378; API